Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.
Watanabe T, Watanabe S, Kim JH, Hatta M, Kawaoka Y.
Watanabe T, et al. Among authors: watanabe s.
J Virol. 2008 Mar;82(5):2486-92. doi: 10.1128/JVI.01899-07. Epub 2007 Dec 26.
J Virol. 2008.
PMID: 18160446
Free PMC article.
Previously, we and others demonstrated that deletions of the M2 cytoplasmic tail caused a growth defect in A/WSN/33 (H1N1) influenza A virus in vitro (K. Iwatsuki-Horimoto, T. Horimoto, T. Noda, M. Kiso, J. Maeda, S. Watanabe, Y. Muramoto, K. ...
Previously, we and others demonstrated that deletions of the M2 cytoplasmic tail caused a growth defect in A/WSN/33 (H1N1) influenza A virus …